187 related articles for article (PubMed ID: 36513089)
1. [Current Management of Basal Cell Carcinoma].
Krieter M; Schultz E
Laryngorhinootologie; 2022 Dec; 101(12):969-978. PubMed ID: 36513089
[TBL] [Abstract][Full Text] [Related]
2. [Current Management of Basal Cell Carcinoma].
Krieter M; Schultz E
Dtsch Med Wochenschr; 2023 Sep; 148(17):1081-1087. PubMed ID: 37611571
[TBL] [Abstract][Full Text] [Related]
3. Basal cell carcinoma: an evidence-based treatment update.
Clark CM; Furniss M; Mackay-Wiggan JM
Am J Clin Dermatol; 2014 Jul; 15(3):197-216. PubMed ID: 24733429
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of basal cell carcinoma : A question of the risk of recurrence].
Lang BM; Grabbe S
Hautarzt; 2020 Aug; 71(8):580-587. PubMed ID: 32533202
[TBL] [Abstract][Full Text] [Related]
5. Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
Stratigos AJ; Sekulic A; Peris K; Bechter O; Prey S; Kaatz M; Lewis KD; Basset-Seguin N; Chang ALS; Dalle S; Orland AF; Licitra L; Robert C; Ulrich C; Hauschild A; Migden MR; Dummer R; Li S; Yoo SY; Mohan K; Coates E; Jankovic V; Fiaschi N; Okoye E; Bassukas ID; Loquai C; De Giorgi V; Eroglu Z; Gutzmer R; Ulrich J; Puig S; Seebach F; Thurston G; Weinreich DM; Yancopoulos GD; Lowy I; Bowler T; Fury MG
Lancet Oncol; 2021 Jun; 22(6):848-857. PubMed ID: 34000246
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Management of Basal Cell Carcinoma.
Tanese K
Curr Treat Options Oncol; 2019 Feb; 20(2):13. PubMed ID: 30741348
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma-treatments for the commonest skin cancer.
Berking C; Hauschild A; Kölbl O; Mast G; Gutzmer R
Dtsch Arztebl Int; 2014 May; 111(22):389-95. PubMed ID: 24980564
[TBL] [Abstract][Full Text] [Related]
8. Interventions for basal cell carcinoma of the skin.
Bath-Hextall FJ; Perkins W; Bong J; Williams HC
Cochrane Database Syst Rev; 2007 Jan; (1):CD003412. PubMed ID: 17253489
[TBL] [Abstract][Full Text] [Related]
9. Interventions for basal cell carcinoma of the skin.
Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003412. PubMed ID: 33202063
[TBL] [Abstract][Full Text] [Related]
10. [What is new in basal cell carcinoma?].
Heppt M; von Braunmühl T; Berking C
Hautarzt; 2016 Nov; 67(11):876-883. PubMed ID: 27654826
[TBL] [Abstract][Full Text] [Related]
11. Advanced basal cell carcinoma.
Wollina U; Tchernev G
Wien Med Wochenschr; 2013 Aug; 163(15-16):347-53. PubMed ID: 23589318
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
Peris K; Fargnoli MC; Garbe C; Kaufmann R; Bastholt L; Seguin NB; Bataille V; Marmol VD; Dummer R; Harwood CA; Hauschild A; Höller C; Haedersdal M; Malvehy J; Middleton MR; Morton CA; Nagore E; Stratigos AJ; Szeimies RM; Tagliaferri L; Trakatelli M; Zalaudek I; Eggermont A; Grob JJ;
Eur J Cancer; 2019 Sep; 118():10-34. PubMed ID: 31288208
[TBL] [Abstract][Full Text] [Related]
13. Current diagnosis and treatment of basal cell carcinoma.
Alter M; Hillen U; Leiter U; Sachse M; Gutzmer R
J Dtsch Dermatol Ges; 2015 Sep; 13(9):863-74; quiz 875. PubMed ID: 26882375
[TBL] [Abstract][Full Text] [Related]
14. Identifying patients at risk for recurrent or advanced BCC.
Hamid O; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1246-52; quiz 1253-4. PubMed ID: 24196332
[TBL] [Abstract][Full Text] [Related]
15. A Review on Imiquimod Therapy and Discussion on Optimal Management of Basal Cell Carcinomas.
Kamath P; Darwin E; Arora H; Nouri K
Clin Drug Investig; 2018 Oct; 38(10):883-899. PubMed ID: 30128748
[TBL] [Abstract][Full Text] [Related]
16. The current clinical approach to difficult-to-treat basal cell carcinomas.
Di Brizzi EV; Argenziano G; Brancaccio G; Scharf C; Ronchi A; Moscarella E
Expert Rev Anticancer Ther; 2023 Jan; 23(1):43-56. PubMed ID: 36579630
[TBL] [Abstract][Full Text] [Related]
17. Systemic Targeted Treatments for Basal Cell Carcinoma.
Svoboda SA; Johnson NM; Phillips MA
Cutis; 2022 Jun; 109(6):E25-E31. PubMed ID: 35960978
[TBL] [Abstract][Full Text] [Related]
18. Japanese Dermatological Association guidelines: Outlines of Japanese clinical guidelines for basal cell carcinoma 2021.
Hoashi T; Ishikawa M; Uehara J; Oashi K; Maeda S; Kato J; Saruta H; Shichinohe R; Ohashi R; Nakamura Y; Koga H; Sugaya M;
J Dermatol; 2024 Apr; 51(4):e90-e105. PubMed ID: 38264942
[TBL] [Abstract][Full Text] [Related]
19. Current Perspectives in the Treatment of Locally Advanced Basal Cell Carcinoma.
Gupta N; Ruiz ES
Drug Des Devel Ther; 2022; 16():183-190. PubMed ID: 35058688
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]